Profile data is unavailable for this security.
About the company
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
- Revenue in USD (TTM)15.79k
- Net income in USD-6.55m
- Incorporated2021
- Employees13.00
- LocationCardio Diagnostics Holdings Inc311 W. Superior Street, Suite 444CHICAGO 60645United StatesUSA
- Phone+1 (302) 281-2147
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDT Equity Inc | 0.00 | -20.70m | 2.14m | 6.00 | -- | 0.3462 | -- | -- | -473.79 | -473.79 | 0.00 | 3.35 | 0.00 | -- | -- | 0.00 | -358.56 | -- | -- | -- | -- | -- | -- | -- | -- | -16.00 | 0.2881 | -- | -- | -- | -3,227.48 | -- | -- | -- |
| Ensysce Biosciences Inc | 4.49m | -10.97m | 2.15m | 7.00 | -- | 1.61 | -- | 0.4798 | -6.36 | -6.36 | 2.32 | 0.3783 | 0.7144 | -- | 5.02 | 641,138.60 | -174.67 | -48.70 | -270.43 | -62.66 | -- | -- | -244.49 | -501.34 | -- | -457.15 | 0.3071 | -- | 133.58 | -- | 24.83 | -- | -- | -- |
| Azitra Inc | 0.00 | -11.12m | 2.16m | 12.00 | -- | 0.494 | -- | -- | -5.49 | -5.49 | 0.00 | 0.4066 | 0.00 | -- | -- | 0.00 | -157.91 | -- | -203.88 | -- | -- | -- | -- | -- | -- | -- | 0.1197 | -- | -98.91 | -- | 29.05 | -- | -- | -- |
| Bluejay Diagnostics Inc | 0.00 | -20.07m | 2.21m | 7.00 | -- | 0.3462 | -- | -- | -134.42 | -134.42 | 0.00 | 9.01 | 0.00 | -- | -- | 0.00 | -103.46 | -70.71 | -124.04 | -82.92 | -- | -- | -- | -12,694.84 | -- | -- | 0.0028 | -- | -- | -- | -110.38 | -- | 119.51 | -- |
| Mosaic Immunoengineering Inc | 0.00 | -671.75k | 2.27m | 2.00 | -- | -- | -- | -- | -0.0928 | -0.0928 | 0.00 | -1.01 | 0.00 | -- | -- | 0.00 | -1,410.50 | -- | -- | -- | -- | -- | -- | -- | -- | -7.37 | -- | -- | -- | -- | 8.56 | -- | -- | -- |
| Purminds Enterprises Inc | 0.00 | -77.46k | 2.36m | 0.00 | -- | 0.0654 | -- | -- | -0.1832 | -0.1832 | 0.00 | 0.7646 | 0.00 | -- | -- | -- | -26.19 | -620.48 | -66.38 | -- | -- | -- | -- | -- | -- | -6.29 | 0.00 | -- | -- | -- | -13.29 | -- | -- | -- |
| Revelation Biosciences Inc | 0.00 | -14.08m | 2.41m | 8.00 | -- | 0.1239 | -- | -- | -120.02 | -120.02 | 0.00 | 12.27 | 0.00 | -- | -- | 0.00 | -82.96 | -- | -118.88 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12,406.06 | -- | -- | -- |
| Ernexa Therapeutics Inc | 1.00k | -18.36m | 2.42m | 6.00 | -- | 0.6787 | -- | 2,422.17 | -5.32 | -5.32 | 0.0002 | 0.4548 | 0.0001 | -- | 0.0059 | 166.67 | -264.07 | -187.10 | -2,044.59 | -237.72 | 100.00 | -- | -1,834,000.00 | -3,375.91 | -- | -2.73 | 0.00 | -- | 755.88 | -50.61 | -105.47 | -- | -19.54 | -- |
| Cardio Diagnostics Holdings Inc | 15.79k | -6.55m | 2.45m | 13.00 | -- | 0.2904 | -- | 154.97 | -4.07 | -4.07 | 0.0097 | 4.61 | 0.0024 | -- | 1.25 | 1,214.62 | -98.75 | -- | -104.31 | -- | -- | -- | -41,495.31 | -- | -- | -440.22 | 0.00 | -- | 104.39 | -- | -0.079 | -- | -- | -- |
| Bone Biologics Corp | 0.00 | -3.95m | 2.55m | 2.00 | -- | 0.4237 | -- | -- | -7.30 | -7.30 | 0.00 | 3.35 | 0.00 | -- | -- | 0.00 | -75.76 | -86.22 | -80.46 | -561.06 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.15 | -- | -- | -- |
| Propanc Biopharma Inc | 0.00 | -63.41m | 2.61m | 1.00 | -- | 0.1809 | -- | -- | -45.47 | -45.47 | 0.00 | 1.08 | 0.00 | -- | -- | 0.00 | -702.98 | -- | -1,223.40 | -- | -- | -- | -- | -- | -- | -56.99 | 0.0422 | -- | -- | -- | -2,826.43 | -- | -- | -- |
| InMed Pharmaceuticals Inc | 4.80m | -8.21m | 2.62m | 13.00 | -- | 0.2101 | -- | 0.5465 | -7.21 | -7.21 | 2.65 | 4.45 | 0.4028 | 3.01 | 15.28 | -- | -68.93 | -87.37 | -78.82 | -107.49 | 33.69 | -- | -171.13 | -356.16 | 6.37 | -27.94 | 0.00 | -- | 7.50 | -- | -6.34 | -- | -- | -- |
| CNS Pharmaceuticals Inc | 0.00 | -13.07m | 2.65m | 4.00 | -- | 0.2476 | -- | -- | -130.83 | -130.83 | 0.00 | 17.25 | 0.00 | -- | -- | 0.00 | -135.60 | -153.00 | -197.11 | -237.57 | -- | -- | -- | -- | -- | -- | 0.0031 | -- | -- | -- | 21.18 | -- | -26.93 | -- |
| Lyra Therapeutics Inc | 600.00k | -32.95m | 2.70m | 30.00 | -- | -- | -- | 4.50 | -23.78 | -23.78 | 0.418 | -2.63 | 0.0098 | -- | -- | 20,000.00 | -53.81 | -64.59 | -67.22 | -76.36 | -- | -- | -5,491.17 | -5,844.58 | -- | -- | -- | -- | -1.54 | -- | -49.07 | -- | 61.78 | -- |
| AIM ImmunoTech Inc | 112.00k | -15.75m | 2.77m | 21.00 | -- | -- | -- | 24.74 | -19.82 | -19.82 | 0.1067 | -2.20 | 0.0117 | -- | -- | 5,333.33 | -165.08 | -50.43 | -637.78 | -55.23 | 15.18 | -113.19 | -14,062.50 | -12,238.47 | -- | -- | -- | -- | -15.84 | 3.96 | 40.20 | -- | -45.22 | -- |
Data as of Feb 10 2026. Currency figures normalised to Cardio Diagnostics Holdings Inc's reporting currency: US Dollar USD
6.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2025 | 35.57k | 1.95% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 20.16k | 1.10% |
| Citadel Securities LLCas of 30 Sep 2025 | 19.52k | 1.07% |
| DRW Securities LLCas of 30 Sep 2025 | 18.17k | 1.00% |
| Geode Capital Management LLCas of 30 Sep 2025 | 15.10k | 0.83% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 3.97k | 0.22% |
| PNC Bank, NA (Investment Management)as of 31 Dec 2025 | 1.35k | 0.07% |
| UBS Securities LLCas of 31 Dec 2025 | 952.00 | 0.05% |
| Tower Research Capital LLCas of 30 Sep 2025 | 788.00 | 0.04% |
| Wolverine Asset Management LLCas of 31 Dec 2025 | 104.00 | 0.01% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
